loading

Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten

pulisher
08:45 AM

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

08:45 AM
pulisher
May 29, 2025

Lantern Pharma Inc. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics, Inc. Announces Oral Presentation at GBA1 Meeting 2025 in Montreal - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting - TradingView

May 29, 2025
pulisher
May 28, 2025

Gain Therapeutics Files $100 Million Mixed Shelf - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Gain Therapeutics (GANX) Pursues $100 Million Securities Offerin - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Gain Therapeutics (GANX) Pursues $100 Million Securities Offering | GANX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings - Benzinga

May 28, 2025
pulisher
May 23, 2025

CytomX Therapeutics Inc’s (CTMX) 4.41% Gain Is A Reason To Reconsider. - Stocksregister

May 23, 2025
pulisher
May 22, 2025

HC Wainwright Brokers Increase Earnings Estimates for GANX - Defense World

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Sells 176,437 Shares of Gain Therapeutics, Inc. (NASDAQ:GANX) - Defense World

May 21, 2025
pulisher
May 21, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of “Buy” by Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Gain Therapeutics (GANX) Maintains 'Buy' Rating with $8 Price Ta - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Roth Capital Predicts Reduced Earnings for Gain Therapeutics - Defense World

May 19, 2025
pulisher
May 15, 2025

Gain Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 15, 2025
pulisher
May 14, 2025

Gain Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Gain (GANX) Advances Parkinson's Treatment in Phase 1b Trials | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics, Inc. Reports Q1 2025 Financial Results and Corporate Update, Highlights Progress in Parkinson’s Disease Drug Development - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics' Parkinson's Drug Shows Promise: Key Biomarker Data Coming Mid-2025 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Zevra Therapeutics Q1 Net Loss Narrows, Revenue Rises; Shares Gain After Hours - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Crude Oil Gains 3%; US Inflation Eases In April - Benzinga

May 13, 2025
pulisher
May 12, 2025

Gain Therapeutics (GANX) Showcases Promising Parkinson's Treatme - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics, Inc. Presents New Evidence for GT-02287 as Potential Disease-Modifying Therapy for Parkinson’s Disease at IAPRD 30th World Congress - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders - TradingView

May 12, 2025
pulisher
May 11, 2025

Gain Therapeutics (GANX) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Halozyme Therapeutics, Inc. (HALO): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Celldex Therapeutics, Inc. (CLDX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Protagonist Therapeutics, Inc. (PTGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Gaining Ground: Verve Therapeutics Inc (VERV) Closes Lower at 5.95, Down -11.33 - DWinneX

May 09, 2025
pulisher
May 09, 2025

Closing Figures Unveiled: Indaptus Therapeutics Inc (INDP) Gain 7.96, Closes at 0.71 - DWinneX

May 09, 2025
pulisher
May 08, 2025

Market Insights: Trevi Therapeutics Inc (TRVI)’s Notable Gain of 1.22, Closing at 6.66 - DWinneX

May 08, 2025
pulisher
May 02, 2025

Gain Therapeutics Inc (GANX) Performance and Fundamentals Dashboard tells a completely different story - Sete News

May 02, 2025
pulisher
May 02, 2025

Market Watch: Soleno Therapeutics Inc (SLNO)’s Noteworthy Gain, Closing at 75.02 - DWinneX

May 02, 2025
pulisher
May 01, 2025

Gain Therapeutics Inc [GANX] Records 50-Day SMA of $1.9700 - knoxdaily.com

May 01, 2025
pulisher
May 01, 2025

Gaining Ground: SpringWorks Therapeutics Inc (SWTX) Closes Higher at 46.30, Up 0.13 - DWinneX

May 01, 2025
pulisher
May 01, 2025

Gain Therapeutics Inc (GANX) Stock: Navigating Drops and Gains - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

Market Watch: ITeos Therapeutics Inc (ITOS)’s Noteworthy Gain, Closing at 7.25 - DWinneX

May 01, 2025
pulisher
May 01, 2025

Gain Therapeutics to Participate at The Citizens Life Sciences Conference - Eagle-Tribune

May 01, 2025
pulisher
May 01, 2025

Gain Therapeutics Inc (GANX) deserves deeper analysis - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Gain Therapeutics CEO to Showcase Next-Gen Allosteric Therapies at Major Healthcare Conference - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

Gain Therapeutics Announces Oral Poster Presentation - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Gain Therapeutics, Inc. Announces Oral Poster Presentation of GT-02287 for Parkinson's Disease at IAPRD 30th World Congress - Nasdaq

Apr 30, 2025
pulisher
Apr 30, 2025

Breakthrough: Novel Drug GT-02287 Demonstrates Neuroprotective Effects in Parkinson's Disease - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

Protara Therapeutics, Inc.'s (NASDAQ:TARA) institutional investors lost 14% last week but have benefitted from longer-term gains - simplywall.st

Apr 30, 2025
pulisher
Apr 29, 2025

Gaining Ground: Structure Therapeutics Inc ADR (GPCR) Closes Lower at 23.62, Down -0.51 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Abeona stock gains on FDA nod for gene therapy (ABEO:NASDAQ) - Seeking Alpha

Apr 29, 2025
pulisher
Apr 25, 2025

Gaining Ground: Abeona Therapeutics Inc (ABEO) Closes Lower at 4.84, Down -0.21 - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

CERo Therapeutics Holdings Inc [CERO] is -81.50% lower this YTD. Is it still time to buy? - dbtnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

EOM Pharmaceuticals (OTCMKTS:IMUC) Stock Price Down 0.8% – Time to Sell? - American Banking and Market News

Apr 25, 2025
pulisher
Apr 25, 2025

Market Insights: Denali Therapeutics Inc (DNLI)’s Notable Gain of 4.17, Closing at 15.49 - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Gain Therapeutics (NASDAQ:GANX) Stock Price Up 1.6% – Here’s Why - American Banking and Market News

Apr 25, 2025
pulisher
Apr 25, 2025

Gain Therapeutics (NASDAQ:GANX) Trading Up 1.6% – Here’s Why - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

GANXGain Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Gaining Ground: Tango Therapeutics Inc (TNGX) Closes Lower at 2.35, Down -0.42 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Gaining Ground: SpringWorks Therapeutics Inc (SWTX) Closes Higher at 41.21, Up 1.75 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Can you now get a good deal on Monte Rosa Therapeutics Inc’s shares? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Gaining Ground: BriaCell Therapeutics Corp (BCTX) Closes Higher at 5.43, Up 1.50 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Summit Therapeutics gains on cancer trial data (SMMT:NASDAQ) - Seeking Alpha

Apr 24, 2025
pulisher
Apr 23, 2025

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight - The Malaysian Reserve

Apr 23, 2025
pulisher
Apr 23, 2025

Gaining Ground: Summit Therapeutics Inc (SMMT) Closes Higher at 27.35, Up 8.45 - DWinneX

Apr 23, 2025
$1.0846
price down icon 1.76%
$29.97
price down icon 0.70%
$577.79
price up icon 0.89%
$306.27
price up icon 0.67%
$4.47
price down icon 2.22%
$489.50
price down icon 0.11%
Kapitalisierung:     |  Volumen (24h):